1 mg tirzepatide microdose 3- Month Micro-dosing Microdosing Tirzepatide Program | No

Monitoring during escalation Active monitoring during dose escalation can catch allodynia symptoms early, before central sensitization has time to become deeply established

On the other hand, some patients mention that the service was slow to get started, which caused frustration at the beginning of care

Licensed clinicians evaluate your unique combination of weight, comorbidities, medication interactions, and kidney function to determine whether semaglutide represents an appropriate first-line option or whether alternative GLP-1 compounds like tirzepatide might better address your specific health profile

Seek immediate medical attention if you develop severe right-sided or upper abdominal pain, persistent nausea and vomiting, yellowing of skin or eyes, or pale stools